{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:53:35Z","timestamp":1789588415889,"version":"build-2803163510"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG-2018 ID: 21663"],"award-info":[{"award-number":["IG-2018 ID: 21663"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>YAP and TAZ are transcriptional regulators essential for mechanotransduction, development, and tissue homeostasis, whose dysregulation is implicated in multiple diseases, including cancer. To identify key regulators of YAP\/TAZ signaling required for breast cancer cell fitness, we performed CRISPR\/Cas9-based loss-of-function genetic screens both in vitro and in vivo. A custom sgRNA library targeting 216 candidate YAP\/TAZ modulators was screened across three breast cancer cell lines. Among these, FERMT2, a component of the integrin signaling pathway, consistently emerged as a strong drop-out hit, highlighting its essential role in sustaining YAP\/TAZ-dependent fitness. Bioinformatic analysis of large-scale cancer datasets further revealed genetic co-dependency between FERMT2, YAP, and TAZ, particularly in tumors with high YAP\/TAZ expression. Functional validation through FERMT2 knockout and silencing demonstrated its requirement for proliferation, anchorage-independent growth, and tumorigenicity in triple-negative breast cancer cells. FERMT2 loss impaired YAP\/TAZ nuclear accumulation, reduced the expression of YAP\/TAZ target genes, and decreased phosphorylation at key tyrosine residues. Mechanistically, FERMT2 regulates YAP\/TAZ independently of the canonical Hippo pathway through integrin-mediated activation of FAK. Consistent with this, glucocorticoid-driven FAK activation restored YAP\/TAZ signaling in FERMT2-depleted cells. Partial epistasis analyses also indicate that FERMT2 modulates actin-dependent regulation of YAP\/TAZ. Together, these findings identify FERMT2 as a pivotal upstream regulator of YAP\/TAZ via FAK signaling, demonstrate that YAP\/TAZ are principal effectors of integrin activity, and suggest that FERMT2 may represent a selective vulnerability in cancers with elevated YAP\/TAZ signaling.<\/jats:p>","DOI":"10.1038\/s41418-026-01694-w","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:58:05Z","timestamp":1772819885000},"page":"1907-1922","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Functional genomic screens uncover FERMT2 as a critical regulator of YAP\/TAZ-driven tumorigenicity"],"prefix":"10.1038","volume":"33","author":[{"given":"Arianna","family":"Chiesa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottavio","family":"Croci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Biagioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0278-3494","authenticated-orcid":false,"given":"Patricio","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Marenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambra","family":"Dondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Rodighiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Filipuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Sberna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Marzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5954-5318","authenticated-orcid":false,"given":"Francesco","family":"Nicassio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8810-6835","authenticated-orcid":false,"given":"Johannes","family":"Zuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4547-6849","authenticated-orcid":false,"given":"Stefano","family":"Campaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"1694_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ceb.2017.12.012","volume":"49","author":"V Fu","year":"2017","unstructured":"Fu V, Plouffe SW, Guan KL. The Hippo pathway in organ development, homeostasis, and regeneration. Curr Opin Cell Biol. 2017;49:99\u2013107.","journal-title":"Curr Opin Cell Biol"},{"key":"1694_CR2","doi-asserted-by":"crossref","unstructured":"Lopez-Hernandez A, Sberna S, Campaner S. Emerging principles in the transcriptional control by YAP and TAZ. Cancers. 2021;13:4242.","DOI":"10.3390\/cancers13164242"},{"key":"1694_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.15698\/cst2021.11.258","volume":"5","author":"G Battilana","year":"2021","unstructured":"Battilana G, Zanconato F, Piccolo S. Mechanisms of YAP\/TAZ transcriptional control. Cell Stress. 2021;5:167\u201372.","journal-title":"Cell Stress"},{"key":"1694_CR4","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","volume":"29","author":"F Zanconato","year":"2016","unstructured":"Zanconato F, Cordenonsi M, Piccolo S. YAP\/TAZ at the roots of cancer. Cancer Cell. 2016;29:783\u2013803.","journal-title":"Cancer Cell"},{"key":"1694_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s43018-022-00473-z","volume":"4","author":"S Piccolo","year":"2023","unstructured":"Piccolo S, Panciera T, Contessotto P, Cordenonsi M. YAP\/TAZ as master regulators in cancer: modulation, function and therapeutic approaches. Nat Cancer. 2023;4:9\u201326.","journal-title":"Nat Cancer"},{"key":"1694_CR6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41568-023-00579-1","volume":"23","author":"JM Franklin","year":"2023","unstructured":"Franklin JM, Wu Z, Guan KL. Insights into recent findings and clinical application of YAP and TAZ in cancer. Nat Rev Cancer. 2023;23:512\u201325.","journal-title":"Nat Rev Cancer"},{"key":"1694_CR7","doi-asserted-by":"crossref","unstructured":"Manning SA, Kroeger B, Harvey KF. The regulation of Yorkie, YAP and TAZ: new insights into the Hippo pathway. Development. 2020;147:dev179069.","DOI":"10.1242\/dev.179069"},{"key":"1694_CR8","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrm3416","volume":"13","author":"G Halder","year":"2012","unstructured":"Halder G, Dupont S, Piccolo S. Transduction of mechanical and cytoskeletal cues by YAP and TAZ. Nat Rev Mol Cell Biol. 2012;13:591\u2013600.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1694_CR9","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.cell.2013.07.042","volume":"154","author":"M Aragona","year":"2013","unstructured":"Aragona M, Panciera T, Manfrin A, Giulitti S, Michielin F, Elvassore N, et al. A mechanical checkpoint controls multicellular growth through YAP\/TAZ regulation by actin-processing factors. Cell. 2013;154:1047\u201359.","journal-title":"Cell"},{"key":"1694_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","volume":"474","author":"S Dupont","year":"2011","unstructured":"Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, et al. Role of YAP\/TAZ in mechanotransduction. Nature. 2011;474:179\u201383.","journal-title":"Nature"},{"key":"1694_CR11","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1038\/emboj.2011.157","volume":"30","author":"L Sansores-Garcia","year":"2011","unstructured":"Sansores-Garcia L, Bossuyt W, Wada K, Yonemura S, Tao C, Sasaki H, et al. Modulating F-actin organization induces organ growth by affecting the Hippo pathway. EMBO J. 2011;30:2325\u201335.","journal-title":"EMBO J"},{"key":"1694_CR12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1083\/jcb.201501025","volume":"210","author":"NG Kim","year":"2015","unstructured":"Kim NG, Gumbiner BM. Adhesion to fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway. J Cell Biol. 2015;210:503\u201315.","journal-title":"J Cell Biol"},{"key":"1694_CR13","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/j.cell.2012.11.027","volume":"151","author":"L Azzolin","year":"2012","unstructured":"Azzolin L, Zanconato F, Bresolin S, Forcato M, Basso G, Bicciato S, et al. Role of TAZ as mediator of Wnt signaling. Cell. 2012;151:1443\u201356.","journal-title":"Cell"},{"key":"1694_CR14","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2015.07.013","volume":"162","author":"HW Park","year":"2015","unstructured":"Park HW, Kim YC, Yu B, Moroishi T, Mo JS, Plouffe SW, et al. Alternative Wnt signaling activates YAP\/TAZ. Cell. 2015;162:780\u201394.","journal-title":"Cell"},{"key":"1694_CR15","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2012.06.037","volume":"150","author":"FX Yu","year":"2012","unstructured":"Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell. 2012;150:780\u201391.","journal-title":"Cell"},{"key":"1694_CR16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ccell.2019.01.009","volume":"35","author":"X Feng","year":"2019","unstructured":"Feng X, Arang N, Rigiracciolo DC, Lee JS, Yeerna H, Wang Z, et al. A platform of synthetic lethal gene interaction networks reveals that the GNAQ uveal melanoma oncogene controls the Hippo pathway through FAK. Cancer Cell. 2019;35:457\u201372.e5.","journal-title":"Cancer Cell"},{"key":"1694_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14073","volume":"8","author":"G Sorrentino","year":"2017","unstructured":"Sorrentino G, Ruggeri N, Zannini A, Ingallina E, Bertolio R, Marotta C, et al. Glucocorticoid receptor signalling activates YAP in breast cancer. Nat Commun. 2017;8:14073.","journal-title":"Nat Commun"},{"key":"1694_CR18","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1083\/jcb.201609037","volume":"215","author":"Z Sun","year":"2016","unstructured":"Sun Z, Guo SS, F\u00e4ssler R. Integrin-mediated mechanotransduction. J Cell Biol. 2016;215:445\u201356.","journal-title":"J Cell Biol"},{"key":"1694_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41580-024-00777-1","volume":"26","author":"MR Chastney","year":"2025","unstructured":"Chastney MR, Kaivola J, Lepp\u00e4nen VM, Ivaska J. The role and regulation of integrins in cell migration and invasion. Nat Rev Mol Cell Biol. 2025;26:147\u201367.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1694_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcp.1137","volume":"189","author":"EH Danen","year":"2001","unstructured":"Danen EH, Yamada KM. Fibronectin, integrins, and growth control. J Cell Physiol. 2001;189:1\u201313.","journal-title":"J Cell Physiol"},{"key":"1694_CR21","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","volume":"110","author":"RO Hynes","year":"2002","unstructured":"Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110:673\u201387.","journal-title":"Cell"},{"key":"1694_CR22","doi-asserted-by":"crossref","unstructured":"Kolasangiani R, Bidone TC, Schwartz MA. Integrin conformational dynamics and mechanotransduction. Cells. 2022;11:3584.","DOI":"10.3390\/cells11223584"},{"key":"1694_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40164-023-00446-7","volume":"12","author":"X Tan","year":"2023","unstructured":"Tan X, Yan Y, Song B, Zhu S, Mei Q, Wu K. Focal adhesion kinase: from biological functions to therapeutic strategies. Exp Hematol Oncol. 2023;12:83.","journal-title":"Exp Hematol Oncol"},{"key":"1694_CR24","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/embj.201386399","volume":"33","author":"K Brami-Cherrier","year":"2014","unstructured":"Brami-Cherrier K, Gervasi N, Arsenieva D, Walkiewicz K, Boutterin MC, Ortega A, et al. FAK dimerization controls its kinase-dependent functions at focal adhesions. EMBO J. 2014;33:356\u201370.","journal-title":"EMBO J"},{"key":"1694_CR25","doi-asserted-by":"crossref","unstructured":"Sberna S, Lopez-Hernandez A, Biancotto C, Motta L, Andronache A, Verhoef LGGC, et al. Identification of BRCC3 and BRCA1 as regulators of TAZ stability and activity. Cells. 2023;12:2431.","DOI":"10.3390\/cells12202431"},{"key":"1694_CR26","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/jnci\/92.14.1185a","volume":"92","author":"FR Miller","year":"2000","unstructured":"Miller FR, Santner SJ, Tait L, Dawson PJ. MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. J Natl Cancer Inst. 2000;92:1185\u20136.","journal-title":"J Natl Cancer Inst"},{"key":"1694_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li W, Xu H, Xiao T, Cong L, Love MI, Zhang F, et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 2014;15:554.","journal-title":"Genome Biol"},{"key":"1694_CR28","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","volume":"170","author":"A Tsherniak","year":"2017","unstructured":"Tsherniak A, Vazquez F, Montgomery PG, Weir BA, Kryukov G, Cowley GS, et al. Defining a cancer dependency map. Cell. 2017;170:564\u201376.e16.","journal-title":"Cell"},{"key":"1694_CR29","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401\u20134.","journal-title":"Cancer Discov"},{"key":"1694_CR30","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486:346\u201352.","journal-title":"Nature"},{"key":"1694_CR31","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/ncb3216","volume":"17","author":"F Zanconato","year":"2015","unstructured":"Zanconato F, Forcato M, Battilana G, Azzolin L, Quaranta E, Bodega B, et al. Genome-wide association between YAP\/TAZ\/TEAD and AP-1 at enhancers drives oncogenic growth. Nat Cell Biol. 2015;17:1218\u201327.","journal-title":"Nat Cell Biol"},{"key":"1694_CR32","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1038\/s41388-024-03166-2","volume":"43","author":"NA Yousafzai","year":"2024","unstructured":"Yousafzai NA, El Khalki L, Wang W, Szpendyk J, Sossey-Alaoui K. Kindlin-2 regulates the oncogenic activities of integrins and TGF-\u03b2 in triple-negative breast cancer progression and metastasis. Oncogene. 2024;43:3291\u2013305.","journal-title":"Oncogene"},{"key":"1694_CR33","first-page":"20","volume":"1","author":"EF Plow","year":"2021","unstructured":"Plow EF, Pluskota E, Bialkowska K. Kindlins as modulators of breast cancer progression. J Breast Cancer Res. 2021;1:20\u20139.","journal-title":"J Breast Cancer Res"},{"key":"1694_CR34","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/ijc.25223","volume":"127","author":"Z An","year":"2010","unstructured":"An Z, Dobra K, Lock JG, Str\u00f6mblad S, Hjerpe A, Zhang H. Kindlin-2 is expressed in malignant mesothelioma and is required for tumor cell adhesion and migration. Int J Cancer. 2010;127:1999\u20132008.","journal-title":"Int J Cancer"},{"key":"1694_CR35","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.amjsurg.2011.06.050","volume":"203","author":"Z Shen","year":"2012","unstructured":"Shen Z, Ye Y, Dong L, Vainionp\u00e4\u00e4 S, Mustonen H, Puolakkainen P, et al. Kindlin-2: a novel adhesion protein related to tumor invasion, lymph node metastasis, and patient outcome in gastric cancer. Am J Surg. 2012;203:222\u20139.","journal-title":"Am J Surg"},{"key":"1694_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.canlet.2015.02.039","volume":"361","author":"J Zhan","year":"2015","unstructured":"Zhan J, Song J, Wang P, Chi X, Wang Y, Guo Y, et al. Kindlin-2 induced by TGF-\u03b2 signaling promotes pancreatic ductal adenocarcinoma progression through downregulation of transcriptional factor HOXB9. Cancer Lett. 2015;361:75\u201385.","journal-title":"Cancer Lett"},{"key":"1694_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08772-3","volume":"10","author":"L Guo","year":"2019","unstructured":"Guo L, Cui C, Zhang K, Wang J, Wang Y, Lu Y, et al. Kindlin-2 links mechano-environment to proline synthesis and tumor growth. Nat Commun. 2019;10:845.","journal-title":"Nat Commun"},{"key":"1694_CR38","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.gene.2015.11.005","volume":"576","author":"JR Yang","year":"2016","unstructured":"Yang JR, Pan TJ, Yang H, Wang T, Liu W, Liu B, et al. Kindlin-2 promotes invasiveness of prostate cancer cells via NF-\u03baB-dependent upregulation of matrix metalloproteinases. Gene. 2016;576:571\u20136.","journal-title":"Gene"},{"key":"1694_CR39","doi-asserted-by":"crossref","unstructured":"Wang W, Rana PS, Alkrekshi A, Bialkowska K, Markovic V, Schiemann WP, et al. Targeted deletion of kindlin-2 in mouse mammary glands inhibits tumor growth, invasion, and metastasis downstream of a TGF-\u03b2\/EGF oncogenic signaling pathway. Cancers. 2022;14:639.","DOI":"10.3390\/cancers14030639"},{"key":"1694_CR40","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41419-022-04945-z","volume":"13","author":"L Ma","year":"2022","unstructured":"Ma L, Tian Y, Qian T, Li W, Liu C, Chu B, et al. Kindlin-2 promotes Src-mediated tyrosine phosphorylation of androgen receptor and contributes to breast cancer progression. Cell Death Dis. 2022;13:482.","journal-title":"Cell Death Dis"},{"key":"1694_CR41","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1158\/0008-5472.CAN-16-2337","volume":"77","author":"K Sossey-Alaoui","year":"2017","unstructured":"Sossey-Alaoui K, Pluskota E, Bialkowska K, Szpak D, Parker Y, Morrison CD, et al. Kindlin-2 regulates the growth of breast cancer tumors by activating CSF-1-mediated macrophage infiltration. Cancer Res. 2017;77:5129\u201341.","journal-title":"Cancer Res"},{"key":"1694_CR42","doi-asserted-by":"publisher","first-page":"6273","DOI":"10.18632\/aging.102187","volume":"11","author":"CY Wei","year":"2019","unstructured":"Wei CY, Zhu MX, Zhang PF, Yang X, Wang L, Ying JH, et al. Elevated kindlin-2 promotes tumour progression and angiogenesis through the mTOR\/VEGFA pathway in melanoma. Aging. 2019;11:6273\u201385.","journal-title":"Aging"},{"key":"1694_CR43","doi-asserted-by":"publisher","first-page":"5626","DOI":"10.1038\/s41388-021-01954-8","volume":"40","author":"S Huang","year":"2021","unstructured":"Huang S, Deng W, Wang P, Yan Y, Xie C, Cao X, et al. Fermitin family member 2 promotes melanoma progression by enhancing the binding of p-\u03b1-Pix to Rac1 to activate the MAPK pathway. Oncogene. 2021;40:5626\u201338.","journal-title":"Oncogene"},{"key":"1694_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00263-3","volume":"7","author":"S Timbrell","year":"2021","unstructured":"Timbrell S, Aglan H, Cramer A, Foden P, Weaver D, Pachter J, et al. FAK inhibition alone or in combination with adjuvant therapies reduces cancer stem cell activity. npj Breast Cancer. 2021;7:65.","journal-title":"npj Breast Cancer"},{"key":"1694_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51424-4","volume":"15","author":"F Nadalin","year":"2024","unstructured":"Nadalin F, Marzi MJ, Pirra Piscazzi M, Fuentes-Bravo P, Procaccia S, Climent M, et al. Multi-omic lineage tracing predicts the transcriptional, epigenetic and genetic determinants of cancer evolution. Nat Commun. 2024;15:7609.","journal-title":"Nat Commun"},{"key":"1694_CR46","first-page":"9","volume":"10","author":"G-H Wu","year":"2024","unstructured":"Wu G-H, He C, Che G, Zhou Z, Chen B-Y, Wu H-M, et al. The role of FERMT2 in the tumor microenvironment and immunotherapy in pan-cancer using comprehensive single-cell and bulk sequencing. Heliyon. 2024;10:9.","journal-title":"Heliyon"},{"key":"1694_CR47","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac558","volume":"24","author":"C-J Liu","year":"2023","unstructured":"Liu C-J, Hu F-F, Xie G-Y, Miao Y-R, Li X-W, Zeng Y, et al. GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinforma. 2023;24:bbac558.","journal-title":"Brief Bioinforma"},{"key":"1694_CR48","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.cell.2013.08.003","volume":"154","author":"A Basu","year":"2013","unstructured":"Basu A, Bodycombe Nicole E, Cheah Jaime H, Price Edmund V, Liu K, Schaefer Giannina I, et al. An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules. Cell. 2013;154:1151\u201361.","journal-title":"Cell"},{"key":"1694_CR49","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1016\/j.celrep.2019.11.035","volume":"29","author":"J Song","year":"2019","unstructured":"Song J, Wang T, Chi X, Wei X, Xu S, Yu M, et al. Kindlin-2 inhibits the Hippo signaling pathway by promoting degradation of MOB1. Cell Rep. 2019;29:3664\u201377.e5.","journal-title":"Cell Rep"},{"key":"1694_CR50","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41419-021-03885-4","volume":"12","author":"X Chi","year":"2021","unstructured":"Chi X, Luo W, Song J, Li B, Su T, Yu M, et al. Kindlin-2 in Sertoli cells is essential for testis development and male fertility in mice. Cell Death Dis. 2021;12:604.","journal-title":"Cell Death Dis"},{"key":"1694_CR51","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1083\/jcb.201612177","volume":"217","author":"L Guo","year":"2018","unstructured":"Guo L, Cai T, Chen K, Wang R, Wang J, Cui C, et al. Kindlin-2 regulates mesenchymal stem cell differentiation through control of YAP1\/TAZ. J Cell Biol. 2018;217:1431\u201351.","journal-title":"J Cell Biol"},{"key":"1694_CR52","doi-asserted-by":"publisher","unstructured":"Deng Q, Yao Q, Wu A, Li J, Li Y, Tang L, et al. TiO2 nanotube enhance osteogenesis through Kindlin-2\/Integrin \u03b21\/YAP pathway-mediated mechanotransduction. Biomed Mater. 2024: https:\/\/doi.org\/10.1088\/1748-605X\/ad7e8f.","DOI":"10.1088\/1748-605X\/ad7e8f"},{"key":"1694_CR53","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jhep.2021.05.018","volume":"75","author":"X Song","year":"2021","unstructured":"Song X, Xu H, Wang P, Wang J, Affo S, Wang H, et al. Focal adhesion kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation. J Hepatol. 2021;75:888\u201399.","journal-title":"J Hepatol"},{"key":"1694_CR54","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature03098","volume":"432","author":"SW Lowe","year":"2004","unstructured":"Lowe SW, Cepero E, Evan G. Intrinsic tumour suppression. Nature. 2004;432:307\u201315.","journal-title":"Nature"},{"key":"1694_CR55","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.10130","volume":"5","author":"M Theodosiou","year":"2016","unstructured":"Theodosiou M, Widmaier M, B\u00f6ttcher RT, Rognoni E, Veelders M, Bharadwaj M, et al. Kindlin-2 cooperates with talin to activate integrins and induces cell spreading by directly binding paxillin. Elife. 2016;5:e10130.","journal-title":"Elife"},{"key":"1694_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47423-0","volume":"15","author":"F Haderk","year":"2024","unstructured":"Haderk F, Chou Y-T, Cech L, Fern\u00e1ndez-M\u00e9ndez C, Yu J, Olivas V, et al. Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer. Nat Commun. 2024;15:3741.","journal-title":"Nat Commun"},{"key":"1694_CR57","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1101\/gad.274951.115","volume":"30","author":"P Li","year":"2016","unstructured":"Li P, Silvis MR, Honaker Y, Lien WH, Arron ST, Vasioukhin V. \u03b1E-catenin inhibits a Src-YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway. Genes Dev. 2016;30:798\u2013811.","journal-title":"Genes Dev"},{"key":"1694_CR58","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/jcb.26246","volume":"119","author":"RL Smoot","year":"2018","unstructured":"Smoot RL, Werneburg NW, Sugihara T, Hernandez MC, Yang L, Mehner C, et al. Platelet-derived growth factor regulates YAP transcriptional activity via Src family kinase dependent tyrosine phosphorylation. J Cell Biochem. 2018;119:824\u201336.","journal-title":"J Cell Biochem"},{"key":"1694_CR59","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/s41419-018-1005-z","volume":"9","author":"A Kedan","year":"2018","unstructured":"Kedan A, Verma N, Saroha A, Shreberk-Shaked M, M\u00fcller A-K, Nair NU, et al. PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein. Cell Death Dis. 2018;9:985.","journal-title":"Cell Death Dis"},{"key":"1694_CR60","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1038\/s41594-023-01139-9","volume":"30","author":"J Aretz","year":"2023","unstructured":"Aretz J, Aziz M, Strohmeyer N, Sattler M, F\u00e4ssler R. Talin and kindlin use integrin tail allostery and direct binding to activate integrins. Nat Struct Mol Biol. 2023;30:1913\u201324.","journal-title":"Nat Struct Mol Biol"},{"key":"1694_CR61","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41580-022-00531-5","volume":"24","author":"P Kanchanawong","year":"2023","unstructured":"Kanchanawong P, Calderwood DA. Organization, dynamics and mechanoregulation of integrin-mediated cell\u2013ECM adhesions. Nat Rev Mol Cell Biol. 2023;24:142\u201361.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1694_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23372-w","volume":"12","author":"T Orr\u00e9","year":"2021","unstructured":"Orr\u00e9 T, Joly A, Karatas Z, Kastberger B, Cabriel C, B\u00f6ttcher RT, et al. Molecular motion and tridimensional nanoscale localization of kindlin control integrin activation in focal adhesions. Nat Commun. 2021;12:3104.","journal-title":"Nat Commun"},{"key":"1694_CR63","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1016\/j.str.2019.09.006","volume":"27","author":"L Zhu","year":"2019","unstructured":"Zhu L, Liu H, Lu F, Yang J, Byzova TV, Qin J. Structural basis of paxillin recruitment by kindlin-2 in regulating cell adhesion. Structure. 2019;27:1686\u201397.e5.","journal-title":"Structure"},{"key":"1694_CR64","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1242\/jcs.161190","volume":"129","author":"E Rognoni","year":"2016","unstructured":"Rognoni E, Ruppert R, F\u00e4ssler R. The kindlin family: functions, signaling properties and implications for human disease. J Cell Sci. 2016;129:17\u201327.","journal-title":"J Cell Sci"},{"key":"1694_CR65","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1096\/fj.201700721R","volume":"32","author":"D Lachowski","year":"2018","unstructured":"Lachowski D, Cortes E, Robinson B, Rice A, Rombouts K, Del R\u00edo Hern\u00e1ndez AE. FAK controls the mechanical activation of YAP, a transcriptional regulator required for durotaxis. FASEB J. 2018;32:1099\u2013107.","journal-title":"FASEB J"},{"key":"1694_CR66","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s13046-022-02396-0","volume":"41","author":"DC Rigiracciolo","year":"2022","unstructured":"Rigiracciolo DC, Nohata N, Lappano R, Cirillo F, Talia M, Adame-Garcia SR, et al. Focal adhesion kinase (FAK)-Hippo\/YAP transduction signaling mediates the stimulatory effects exerted by S100A8\/A9-RAGE system in triple-negative breast cancer (TNBC). J Exp Clin Cancer Res. 2022;41:193.","journal-title":"J Exp Clin Cancer Res"},{"key":"1694_CR67","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41419-022-05224-7","volume":"13","author":"J Li","year":"2022","unstructured":"Li J, Zhang X, Hou Z, Cai S, Guo Y, Sun L, et al. P130cas-FAK interaction is essential for YAP-mediated radioresistance of non-small cell lung cancer. Cell Death Dis. 2022;13:783.","journal-title":"Cell Death Dis"},{"key":"1694_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1274209","volume":"15","author":"HH Hu","year":"2024","unstructured":"Hu HH, Wang SQ, Shang HL, Lv HF, Chen BB, Gao SG, et al. Roles and inhibitors of FAK in cancer: current advances and future directions. Front Pharmacol. 2024;15:1274209.","journal-title":"Front Pharmacol"},{"key":"1694_CR69","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/13543784.2020.1740680","volume":"29","author":"A Mohanty","year":"2020","unstructured":"Mohanty A, Pharaon RR, Nam A, Salgia S, Kulkarni P, Massarelli E. FAK-targeted and combination therapies for the treatment of cancer: an overview of phase I and II clinical trials. Expert Opin Investig Drugs. 2020;29:399\u2013409.","journal-title":"Expert Opin Investig Drugs"},{"key":"1694_CR70","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/ncb2936","volume":"16","author":"G Sorrentino","year":"2014","unstructured":"Sorrentino G, Ruggeri N, Specchia V, Cordenonsi M, Mano M, Dupont S, et al. Metabolic control of YAP and TAZ by the mevalonate pathway. Nat Cell Biol. 2014;16:357\u201366.","journal-title":"Nat Cell Biol"},{"key":"1694_CR71","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1038\/s41556-025-01773-z","volume":"27","author":"G Vanni","year":"2025","unstructured":"Vanni G, Citron A, Suli A, Contessotto P, Caire R, Gandin A, et al. Microtubule architecture connects AMOT stability to YAP\/TAZ mechanotransduction and Hippo signalling. Nat Cell Biol. 2025;27:1725\u201338.","journal-title":"Nat Cell Biol"},{"key":"1694_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07901-8","volume":"9","author":"KR Sanson","year":"2018","unstructured":"Sanson KR, Hanna RE, Hegde M, Donovan KF, Strand C, Sullender ME, et al. Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities. Nat Commun. 2018;9:5416.","journal-title":"Nat Commun"},{"key":"1694_CR73","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","volume":"18","author":"C Stringer","year":"2021","unstructured":"Stringer C, Wang T, Michaelos M, Pachitariu M. Cellpose: a generalist algorithm for cellular segmentation. Nat Methods. 2021;18:100\u20136.","journal-title":"Nat Methods"},{"key":"1694_CR74","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1694_CR75","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cell.2011.09.048","volume":"147","author":"M Cordenonsi","year":"2011","unstructured":"Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Frasson C, et al. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell. 2011;147:759\u201372.","journal-title":"Cell"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01694-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01694-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01694-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:35:52Z","timestamp":1788514552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01694-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":75,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1694"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01694-w","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}